| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 04/26/2006 | EP1648446A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648445A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648444A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | CN1764641A Viral polymerase inhibitors |
| 04/26/2006 | CN1253458C Process for preparing substance GM-95 |
| 04/20/2006 | WO2006040966A1 Aromatic-ring-fused pyrimidine derivative |
| 04/20/2006 | WO2006040281A1 Thiazolyl-dihydro indazoles |
| 04/20/2006 | WO2006040279A1 Pi3 kinases |
| 04/20/2006 | WO2006040151A1 Subsituted hydroxyethylamine compounds for treating alzheimer’s disease |
| 04/20/2006 | WO2006040149A1 Heterocyclic ketone compounds for treating alzheimer’s disease |
| 04/20/2006 | WO2006040148A1 Tricyclic indole derivatives for use in the treatment of alzheimer’s disease |
| 04/20/2006 | WO2005111039A3 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 04/20/2006 | US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance |
| 04/20/2006 | US20060084643 6-Fluoro-10-[3-(2-methoxy-ethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene; dopamine D2 and serotonin receptor anatagonist; neuroleptic agent, antidepressnt; psychological, bipolar disorders, psychosis, schizophrenia, acute mania |
| 04/20/2006 | CA2579288A1 Thiazolyldihydroindazoles |
| 04/20/2006 | CA2579279A1 Tricyclic thiazole derivatives as pi3 kinases |
| 04/19/2006 | EP1647553A1 2-acylaminothiazole derivative or salt thereof |
| 04/19/2006 | EP1646615A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 04/19/2006 | EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 04/19/2006 | EP1212330B1 Androgen receptor modulator compounds and methods |
| 04/19/2006 | EP1196167B1 Use of p38 MAPK inhibitors in the treatment of ophthalmic conditions |
| 04/19/2006 | EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 04/19/2006 | CN1761673A Guanidine derivatives and use thereof as neuropeptide FF receptor antagonists |
| 04/19/2006 | CN1761672A Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 04/19/2006 | CN1761651A 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/13/2006 | WO2005118549A3 Compounds having affinity for dopamine d3 receptor and uses thereof |
| 04/13/2006 | WO2005049559A3 Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) |
| 04/13/2006 | US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 04/13/2006 | US20060079677 Novel tricyclic azepine derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 04/13/2006 | US20060079549 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength |
| 04/13/2006 | DE102004048877A1 New tricyclic thiazole derivatives useful as PI3 kinase inhibitors, for treating e.g. inflammatory and allergic airway and skin diseases, autoimmune and kidney disease |
| 04/12/2006 | EP1644337A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/12/2006 | EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1087981B1 Prenyl transferase inhibitors |
| 04/12/2006 | CN1757645A Material contg. thiophene spirane structure, its synthesis and application |
| 04/11/2006 | US7026313 2-thia-1,6,8-triaza-naphthalene-2,2-dioxides are kinase inhibitors |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 04/05/2006 | EP1641805A1 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 04/05/2006 | EP1173427B1 Hydroxamic acid derivative |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/04/2006 | US7022850 Bicyclicpyrimidones and their use to treat diseases |
| 04/04/2006 | US7022701 for treatment of disorders (sleeping, feeding) relating to or affected by the 5-HT6 receptor; serotonin receptor antagonists |
| 04/04/2006 | US7022667 Mycobacterium; grampositive bacteria bactericides, antibiotics |
| 04/04/2006 | US7022317 Heterocyclic derivatives of 2-oxothiazolidine-4-carboxylic acid, and use as active photoprotective agents |
| 04/04/2006 | CA2354123C New benzothiadiazine derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 04/04/2006 | CA2235133C Esters of 3-hydroxy-piperidinemethanol derivatives |
| 03/30/2006 | WO2006034113A2 Quinolone analogs as cell proliferation inhibitors |
| 03/30/2006 | WO2005113536A3 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 03/30/2006 | WO2005097107A3 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
| 03/30/2006 | US20060069116 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/30/2006 | US20060069109 Therapeutic agents |
| 03/30/2006 | CA2580749A1 Quinolone analogs |
| 03/30/2006 | CA2580725A1 Novel heterocyclic nf-kb inhibitors |
| 03/29/2006 | EP1638957A1 N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 03/29/2006 | CN1753899A Spirotetrathiocarbamates and spirooxothiocarbamates |
| 03/29/2006 | CN1753897A Fused bicyclic nitrogen-containing heterocycles |
| 03/28/2006 | US7018960 Formed by inter-molecular interaction of one or more keto-enol tautomeric compounds; for mechanical friction sliding members |
| 03/23/2006 | US20060063798 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
| 03/22/2006 | EP1637533A1 Substituted thiazolopyrimidines as analgetics |
| 03/22/2006 | EP1636242A1 Acylated imidazo (2,1-b) -1,3,4,-thiadia zole-2-sulfonamides, and uses thereof |
| 03/22/2006 | EP1636241A1 Imidazo (2,1-b) -1,3,4-thiadiazole sulfoxides and sulfones |
| 03/22/2006 | EP1635829A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | CN1751052A Therapeutic agents |
| 03/22/2006 | CN1751047A Triazole compounds useful in therapy |
| 03/21/2006 | US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/21/2006 | US7015321 Synthesis of non-symmetrical sulfamides using burgess-type reagents |
| 03/21/2006 | US7015212 Thiazepine inhibitors of HIV-1 integrase |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2005016235A3 Combined use of impdh inhibitors with toll-like receptor agonists |
| 03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
| 03/16/2006 | US20060058287 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
| 03/16/2006 | US20060058259 Human t-cell,lymphocyte virus; hepatitis virus |
| 03/15/2006 | EP1633758A2 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 |
| 03/15/2006 | EP1633725A1 Hepatitis c virus inhibitors |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | CN1747957A Intermediate for 2-substituted carbapenem derivative and production process |
| 03/15/2006 | CN1747951A Novel 2-pyridinecarboxamide derivatives |
| 03/15/2006 | CN1747949A Acyclic pyrazole compounds |
| 03/15/2006 | CN1746172A Preparation of plurichari |
| 03/15/2006 | CN1245660C Color coupler for forming dye, silver halide photosensitive material and azomethine dyes compounds |
| 03/14/2006 | US7012087 Anticancer agents |
| 03/14/2006 | US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction |
| 03/14/2006 | CA2165800C Antiallergic imidazoazepines |
| 03/09/2006 | WO2006024535A1 Substituted indole compounds and their use as 5-ht6 receptor modulators |
| 03/09/2006 | US20060052612 Bis-4,7-(5'-(2-fluorophenyl)-2'-thienyl)-2,1,3-benzothiadiazole; emission color of the compounds of can be adjusted over the entire visible region, i.e. from deep blue to deep red, by choice of an appropriate substitution pattern; high current densities |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052400 Immunosuppressants; respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 03/09/2006 | US20060052372 N-(Heterocycloalkyl)alkylsulfonamides, e.g., N-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-N-(4-methoxyphenyl)-propanesulfonamide; improve blood flow to the optic nerve head and the retina ; used to treat retinal diseases, sleep disorders, depression, schizophrenia, anxiety, OCD, etc. |
| 03/09/2006 | CA2577925A1 Substituted indole compounds and their use as 5-ht6 receptor modulators |
| 03/08/2006 | EP1632494A1 Vasopressin v1a antagonists |
| 03/08/2006 | EP1632491A1 Substituted indole compounds and their use as 5-HT6 receptor modulators |
| 03/08/2006 | EP1445252B1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 03/08/2006 | EP1339723B1 Process and ester derivatives useful for preparation of cephalosporins |
| 03/08/2006 | EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 03/08/2006 | CN1745087A Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same |